A randomized controlled trial (RCT) published in Psychological Medicine demonstrates a significant and clinically relevant reduction in ADHD symptoms in adults using the digital therapy "attexis." ...
Severe acute pancreatitis is frequently complicated by hospital-acquired infections that worsen outcomes and prolong intensive care stays. New evidence suggests that modulating the microbiome may ...
First High-Quality Study to Explore A Carnivore-Style Diet in Managing Metabolic Health, WhichAffects Millions of AmericansOver one-third of U.S. adults – or 115.2 million Americans – are prediabetic, ...
Initial treatments are underway in randomized study of Acorn’s personalized autologous injectable for improving facial ...
MFDS IND approval enables a multicenter, randomized, double-blind, vehicle-controlled phase 2 study in ~150 DED patients, randomized 1:1:1 to two dosing arms versus control over 12 weeks. Prior phase ...
An international, randomized, double-blind, placebo-controlled Phase III study—the largest of its kind for mpox—found that tecovirimat did not improve clinical outcomes for adults with clade II mpox ...
High-dose Vitamin D doesn't reduce acute COVID severity but shows a promising signal for reducing Long COVID and brain fog.
When Elise Felicione tried to design a clinical trial for a supplement, 5 things got in the way. It’s a lesson for the industry.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results